TDOC logo

Teladoc Health Inc. (TDOC)

$6.26

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on TDOC

Market cap

$1.14B

EPS

-0.99

P/E ratio

--

Price to sales

0.46

Dividend yield

--

Beta

2.12445

Price on TDOC

Previous close

$6.34

Today's open

$6.25

Day's range

$6.23 - $6.39

52 week range

$4.40 - $9.89

Profile about TDOC

CEO

Charles Divita

Employees

5600

Headquarters

New York, NY

Exchange

New York Stock Exchange

Shares outstanding

181684021

Issue type

Common Stock

TDOC industries and sectors

Healthcare

Healthcare Providers & Services

News on TDOC

Here's Why Investors Should Stay Neutral on TDOC Stock for Now

Teladoc Health's growth is supported by chronic care, international expansion and Teladoc One, but BetterHelp weakness and losses temper the outlook.

news source

Zacks Investment Research • 4 hours ago

news preview

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health said on Monday it appointed Michael Grasher as its chief financial officer, bringing in an ​industry veteran to help the virtual healthcare company navigate ‌rising demand for its insurance-covered business.

news source

Reuters • Aug 31, 2026

news preview

Teladoc Health Appoints Michael Grasher as Chief Financial Officer

Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth  NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Michael Grasher as Chief Financial Officer, effective immediately. Mr. Grasher is an accomplished financial executive with more than three decades of experience across the insurance and financial services sectors, including more than 12 years in CFO roles at public and privately held companies.

news source

GlobeNewsWire • Aug 31, 2026

news preview

Teladoc (TDOC) Down 3.3% Since Last Earnings Report: Can It Rebound?

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?

news source

Zacks Investment Research • Aug 28, 2026

news preview

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

news source

PRNewsWire • Aug 27, 2026

news preview

BetterHelp Has the Demand: Can Teladoc Build the Capacity?

TDOC's BetterHelp faces a capacity crunch as insurance demand surges, putting therapist recruitment and credentialing at the center.

news source

Zacks Investment Research • Aug 24, 2026

news preview

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Teladoc Health, Inc. – TDOC

NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

news source

GlobeNewsWire • Aug 18, 2026

news preview

Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights.   We would handle the matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

news source

PRNewsWire • Aug 17, 2026

news preview

Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

Teladoc Health shares fell more than 28% after the Company reported Q2 2026 revenue of $606.9 million and cut its full-year 2026 revenue guidance. Levi & Korsinsky investigates.

news source

PRNewsWire • Aug 7, 2026

news preview

Teladoc Health Inc. (TDOC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Teladoc Health Inc. (“Teladoc” or the “Company”) (NYSE: TDOC) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN TELADOC HEALTH INC. (TDOC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by ema.

news source

Business Wire • Aug 6, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Teladoc Health Inc.

Open an M1 investment account to buy and sell Teladoc Health Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in TDOC on M1